Viewing StudyNCT01420055



Ignite Creation Date: 2024-05-05 @ 11:48 PM
Last Modification Date: 2024-10-26 @ 10:39 AM
Study NCT ID: NCT01420055
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2011-08-17

Brief Title: Fingolimod -Response According to Coping - Evaluation
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Multiple Sclerosis Relapsing-Remitting
Keywords:
Name View
Multiple sclerosis View
Fingolimod View
Coping View
Anxiety View
France View
Treatment Satisfaction Questionnaire for Medication-9 items TSQM 9 View
Active View